ストックスクリーナーアプリを入手
3.21
0.31%
-0.01
アフターアワーズ：
3.21
前日終値:
$3.22
開ける：
$3.19
24時間の取引高:
464.79K
Relative Volume:
0.39
時価総額：
$297.56M
収益：
-
当期純損益:
$-39.95M
株価収益率:
-6.9047
EPS:
-0.4649
ネットキャッシュフロー:
$-34.08M
1週間 パフォーマンス:
-5.31%
1か月 パフォーマンス:
+34.31%
6か月 パフォーマンス:
-20.54%
1年 パフォーマンス:
-67.72%
1日の値動き範囲:
$3.152
$3.23
1週間の範囲:
$3.14
$3.57
52週間の値動き範囲:
$2.255
$10.40
Anavex Life Sciences Corp Stock (AVXL) Company Profile
Compare AVXL vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corp
|
3.21 | 298.48M | 0 | -39.95M | -34.08M | -0.4649 |
VRTX
Vertex Pharmaceuticals Inc
|
515.55 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.93 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
987.84 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
212.00 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.51 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Anavex Life Sciences Corp Stock (AVXL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-12-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | 開始されました | Berenberg | Buy |
| 2021-09-23 | 開始されました | BTIG Research | Buy |
| 2020-12-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-28 | 開始されました | Ladenburg Thalmann | Buy |
| 2020-02-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-06-18 | 開始されました | Janney | Buy |
| 2018-05-16 | 再開されました | Maxim Group | Buy |
| 2018-03-08 | 開始されました | ROTH Capital | Buy |
| 2018-02-13 | 繰り返されました | Maxim Group | Buy |
| 2017-09-29 | 再開されました | Noble Financial | Buy |
| 2017-02-07 | 開始されました | Noble Financial | Buy |
| 2016-03-29 | 開始されました | FBR Capital | Outperform |
すべてを表示
Anavex Life Sciences Corp (AVXL) 最新ニュース
Anavex Urges Shareholders to Back Six Director Nominees Ahead of 2026 Annual Meeting - Yahoo Finance
Form 8K Anavex Life Sciences Corp For: 17 August By Investing.com - Investing.com India
Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees - manilatimes.net
Six Anavex Director Nominees Face a Sept. 24 Vote—What Sets Them Apart? - Stock Titan
Promising Penny Stocks To Consider In August 2026 - Sahm
(AVXL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Anavex Life Sciences Corp (AVXL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anavex Life Sciences Files Proxy, Urges Director Support - The Globe and Mail
Anavex Life Sciences Corp. (NASDAQ:AVXL) Receives Consensus Rating of "Hold" from Analysts - marketbeat.com
Anavex urges shareholders to back board slate amid proxy fight By Investing.com - Investing.com UK
Anavex Life Sciences files definitive proxy, urges vote for six director nominees ahead of Sept. 24 meeting - TradingView
Anavex Life Sciences Faces September Board Vote as Blarcamesine Regulatory Strategy Advances - Yahoo Finance
Anavex urges shareholders to back board slate amid proxy fight - Investing.com
Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders - manilatimes.net
Anavex Life Sciences Files Definitive Proxy Statement and Urges Stockholders to Vote for All Six Director Nominees on WHITE Card - Quiver Quantitative
Anavex Life Sciences Corp Solicits Proxies from Shareholders - marketscreener.com
Anavex Life Sciences (NASDAQ:AVXL) Stock Crosses Above 50-Day Moving AverageWhat's Next? - marketbeat.com
Anavex Life Sciences (NASDAQ: AVXL) delays two 2026 quarterly SEC reports - Stock Titan
Anavex Life Sciences Corp (AVXL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AVXL Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
Anavex Life Sciences Corp expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 509% Upside in Biotech - DirectorsTalk Interviews
Anavex Life Sciences Corp. Revenue Breakdown – NASDAQ:AVXL - TradingView
Anavex Life Sciences (NASDAQ:AVXL) Rallies Today on clinical-stage momentum - Kalkine Media
Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - anavex.com
Press Release: Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - moomoo.com
Weekly Recap: IND filing for blarcamesine and Q2 loss, cash runway - TradingView
[PREC14A] ANAVEX LIFE SCIENCES CORP. Preliminary Contested Proxy Statement - Stock Titan
Vanguard Capital Management (NASDAQ: AVXL) discloses 5.03% beneficial stake in Anavex - Stock Titan
Anavex Life Sciences: Fiscal Q2 Earnings Snapshot - king5.com
Anavex Life Sciences (NASDAQ:AVXL) Releases Earnings Results, Beats Expectations By $0.01 EPS - marketbeat.com
Anavex Life Sciences Corp (AVXL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anavex Life Sciences Corp (AVXL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anavex Life Sciences Corp (AVXL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anavex Life Sciences Corp (AVXL) Balance Sheet - TradingKey
Anavex Life Sciences Corp (AVXL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AVXL|Anavex Life Sciences Corp|Price:2.400|Chg%:-0.080 - TradingKey
Anavex Life Sciences Corp (AVXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anavex Life Sciences Corp (AVXL) Income Statement - TradingKey
AVXL|Anavex Life Sciences Corp|Price:2.532|Chg%:+0.032 - TradingKey
Anavex Life Sciences Corp. Revenue Breakdown – SWB:12X1 - TradingView
TradingKey - TradingKey
PVG targets full board replacement at Anavex Life Sciences (NASDAQ: AVXL) - Stock Titan
Trading Systems Reacting to (AVXL) Volatility - Stock Traders Daily
Anavex Submits Nasdaq Compliance Plan After Filing Delay - The Globe and Mail
Anavex Life Sciences Submits Plan to Regain Compliance With Nasdaq Timely Filing Rule - marketscreener.com
Anavex Life Sciences submits compliance plan to Nasdaq after 10-Q delay - TradingView
Anavex Life Sciences Corp. (NASDAQ:AVXL) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Axel Paeger Net Worth (2026) - GuruFocus
CNXU Stock Price and Chart — NASDAQ:CNXU - TradingView
AVXL Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock HigherRevenue Growth Outlook - dars.gov.et
Anavex Life Sciences Corp (AVXL) 財務データ
収益
当期純利益
現金流量
EPS
1.80%
1.77%
大文字化:
|
ボリューム (24 時間):